Cipher Pharmaceuticals Inc. announced the appointment of Lynne Bulger as Vice President, Medical and Clinical Affairs to lead the company's clinical development and medical affairs efforts for current and new pipeline products. Ms. Bulger has 27 years of experience in drug development in the pharmaceutical industry, conducting clinical research and providing strategic medical marketing support in dermatology, rheumatology, osteoporosis and CNS. Most recently, Ms. Bulger held the position of Director Medical Affairs at Stiefel.

In addition to this appointment, Cipher promoted Peter Weiler to the position of Vice President, Business Development and Linda Angaritis to the position of Vice President, Global Regulatory Compliance and Quality. Mr. Weiler has been with Cipher since 2008. Ms. Angaritis joined Cipher in 2013.